Skip to main content
An official website of the United States government
Grant Details

Grant Number: 5R01CA219060-05 Interpret this number
Primary Investigator: Nan, Xiaoli
Organization: Univ Of Maryland, College Park
Project Title: Framing HPV Vaccination Messages for African American Parents
Fiscal Year: 2022


Abstract

PROJECT SUMMARY The 2014 President’s Cancer Panel called underuse of HPV vaccines “a serious, but correctable threat to progress against cancer.” The Cancer Moonshot Blue Ribbon Panel, more recently, identified expanding the use of HPV vaccines as a top priority for cancer prevention, especially in medically underserved populations. The overarching goal of the proposed project is to develop and evaluate a novel, theory-based message framing intervention to accelerate HPV vaccine uptake among African American adolescents. Based on prospect theory and the health belief model, this project aims to 1) develop culturally appropriate messages framed in gains and losses and pretest these messages through community engagement; 2) determine whether/how the effects of message framing (gain vs. loss) on African American parents’ acceptance of the HPV vaccine are moderated by their prior beliefs about HPV and the HPV vaccine; and 3) evaluate the efficacy of a message framing intervention rooted in message targeting principles utilizing mobile tablets for efficient targeting through a clinic-based randomized trial. The proposed project will generate key insights into the persuasive effects of message framing as applied to the promotion of HPV vaccination. It will produce solid empirical evidence surrounding a novel, theory-based message framing intervention aimed at accelerating HPV vaccine uptake among African American adolescents. Addressing a critical aspect of health disparities disadvantaging the African American community, this research represents a systematic and timely effort to respond to the call of the 2014 President’s Cancer Panel on the urgency of optimizing communication strategies for promoting HPV vaccination among key stakeholders.



Publications


None

Back to Top